Clinical Trials Logo

Parkinson's Hallucinations clinical trials

View clinical trials related to Parkinson's Hallucinations.

Filter by:
  • Active, not recruiting  
  • Page 1

NCT ID: NCT04167813 Active, not recruiting - Clinical trials for Dementia With Lewy Bodies

Trial of Ondansetron as a Parkinson's HAllucinations Treatment

TOP HAT
Start date: October 1, 2021
Phase: Phase 2
Study type: Interventional

TOPHAT (Trial of Ondansetron as a Parkinson's HAllucinations Treatment) is a double blind, individually randomized, placebo-controlled, parallel group, flexible dose trial of ondansetron (8-24mg/day) as a treatment for Parkinson's hallucinations, with a 12-week primary outcome and follow-up to 24 weeks.